Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH
type: MedicalStudy
description: Efficacy and Safety of Roflumilast in Patients with Non-Alcoholic Steatohepatitis
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2022-04-01
end date: 2024-10-15
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06677788
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Tanta University
study subject: Non-Alcoholic Steatohepatitis (NASH)
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Non-Alcoholic Steatohepatitis (NASH)

AI Analytics
type: Organization